Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
White Sands Pharma
AddedMar 20, 2024
UpdatedJun 18, 2026
White Sands Pharma

White Sands Pharma

Seed

Innovative pharma company developing novel IBS treatments.

HQ
Little Rock, AR, US
Founded
2014
Overview
Compare
Fundraising
Employees

White Sands Pharma is an innovative pharmaceutical company focused on developing novel treatments for Irritable Bowel Syndrome (IBS). Their mission is to provide effective, narrative-driven solutions to improve the quality of life for IBS patients. The company targets the healthcare market, offering cutting-edge therapies designed to address the unmet needs of those suffering from this chronic condition.

White Sands Pharma has made significant strides in the pharmaceutical industry, gaining recognition for its groundbreaking research and development efforts. Their innovative approach has attracted attention from key stakeholders and investors, positioning the company as a leader in IBS treatment innovation.

White Sands Pharma - Similar Companies

Telsar Pharma logo

Telsar Pharma

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Solaris Pharma logo

Solaris Pharma

solaris-pharma.com

Precision IBD logo

Precision IBD

Outpost Medicine logo

Outpost Medicine

Inflammatory Response Research logo

Inflammatory Response Research

irrinc.net

Sarkana Pharma logo

Sarkana Pharma

PleoPharma logo

PleoPharma

pleopharma.com

Inception IBD logo

Inception IBD

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

Woolsey Pharmaceuticals logo

Woolsey Pharmaceuticals

woolseypharma.com

6S Pharma logo

6S Pharma

6spharma.com

EIR Pharmaceuticals logo

EIR Pharmaceuticals

Tioga Pharmaceuticals logo

Tioga Pharmaceuticals

ISI Life Sciences logo

ISI Life Sciences

White Sands Pharma - Quick Facts

Who are White Sands Pharma's competitors?

Companies similar to White Sands Pharma include Telsar Pharma, Aria Pharmaceuticals, Solaris Pharma and Precision IBD.

When was White Sands Pharma founded?

White Sands Pharma was founded in 2014.

Where is White Sands Pharma's headquarters located?

White Sands Pharma's headquarters is located in Little Rock, AR, US.

When was White Sands Pharma's last funding round?

White Sands Pharma's most recent funding round was for $4.3M (USD) in January 2016.

How much has White Sands Pharma raised to-date?

As of Jan 16, 2016, White Sands Pharma has raised a total of $4.3M (USD).

How many employees does White Sands Pharma have?

White Sands Pharma has 6 employees as of Feb 5, 2024.

White Sands Pharma - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified